Clinical Efficacy of Ruxolitinib Monotherapy and Haploidentical Hematopoeitic Stem Cell Transplantation in a Child with Philadelphia Chromosome-like Relapsed/Refractory acute lymphoblastic leukemia.
Nihan BayramYöntem YamanKürşat ÖzdilliLeyla TelhanSerdar NepesovHülya BilgenMurat ElliSude Sema BeharSema AnakPublished in: Pediatric transplantation (2021)
The circumstance that makes our case featured is the usage of ruxolitinib as monotherapy. This report, we believe, is a pioneering report for a frequent disease with a high risk of failure for the outcome.